Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06523569 · ClinicalTrials.gov registry record · NA

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

A NA study of Gestational Hypertension and Hypertension in Pregnancy, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06523569 is a NA study of Gestational Hypertension and Hypertension in Pregnancy that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 120 participants, below the 1,351-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06523569, a NA study of Gestational Hypertension and Hypertension in Pregnancy, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).

Interventions

  • OTHER Mobile health application
  • OTHER Digital Blood Pressure Monitoring System

Study Locations (1)

Illinois

  • Northwestern University, Dept. of Cardiology - Chicago

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-11-07
Est. Completion 2026-06-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT06523569

The ClinicalTrials.gov registry entry for NCT06523569 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,351-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Gestational Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Mobile health application is the first listed.

NCT06523569 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06523569 about?

NCT06523569 is a clinical study titled "Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy". The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).

What is the current status of trial NCT06523569?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-11-07. Estimated completion is 2026-06-30.

What conditions does trial NCT06523569 study?

This clinical trial studies the following conditions: Gestational Hypertension, Hypertension in Pregnancy, Pre-Eclampsia, Eclampsia.

What interventions are being tested in trial NCT06523569?

The interventions under investigation include: Mobile health application (OTHER), Digital Blood Pressure Monitoring System (OTHER).

Who is sponsoring clinical trial NCT06523569?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06523569 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.